AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced that the American Urological Association has recommended the use of the UroLift System as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. AUA recommends use of UroLift System for managing lower urinary tract symptoms attributed to BPH